|
Status |
Public on Jun 16, 2023 |
Title |
Identification of KPNA2 targets by RNA-Seq in osteosarcoma |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Despite recent advances, the poor outcomes in osteosarcoma suggest that novel therapeutic targets are needed. Karyopherin alpha 2 (KPNA2) is a nuclear import factor, which functions as an oncogene in many cancers. However, the role of KPNA2 in osteosarcoma and its mechanism of action are still unclear. To identify gene signatures that play a role in metastasis, we performed RNA-Seq of gene expression profiling on U2OS cells treated with siKPNA2 and siNC (in triplicate for each group).
|
|
|
Overall design |
U2OS cells were treated with siKPNA2 and siNC (in triplicate for each group).
|
|
|
Contributor(s) |
Zhou S, Liu R |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Jun 17, 2022 |
Last update date |
Jun 16, 2023 |
Contact name |
Sheng Zhou |
E-mail(s) |
zhou415098@sina.com
|
Phone |
+8615007159325
|
Organization name |
The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University
|
Street address |
29 Xinlong Lane
|
City |
Changzhou |
State/province |
Jiangsu |
ZIP/Postal code |
213003 |
Country |
China |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA850355 |